CD8A and acute myeloid leukemia: Notably, in AML, KLRB1high CD8+ TRM exhibited elevated expression of multiple exhaustion‐related markers such as TOX, LAG3, TIGIT, and CD160, except PDCD1, whose expression pattern was opposite from that of KLRB1 (Figure 7D).